Researchers determined that POU Class 4 Homeobox 1 (Pou4f1), a direct Smad3 target gene in the TGF-β1-induced MMT process in BMDMs, was a potential therapeutic target to prevent renal fibrosis. The gene discussed is SMAD3; the disease is renal fibrosis.